On May 14, 2026, Claritev Corp CTEV experienced a significant decline of 15% following news of a Justice Department investigation regarding antitrust issues. The DOJ has initiated a criminal inquiry into potential price-fixing practices, with a focus on the company's Data iSight pricing tool. This development comes as officials engage with third parties to gather more information.
- Market Cap: $400.11 million
- GF Scoreâ„¢: 58/100, indicating a moderate potential for long-term returns
- Financial Strength: Claritev Corp displays poor financial strength, with an Altman Z-score of -0.44, indicating a distress zone and potential bankruptcy risk in the next two years.
What's Behind the News?
The announcement of a Justice Department investigation into Claritev Corp has sent shockwaves through the market, leading to a sharp decline in its stock price. The investigation centers around allegations of price-fixing related to the company's Data iSight pricing tool, which is a critical component of its service offerings. Such legal scrutiny can have significant implications for the company's operational integrity and market reputation, potentially affecting its future revenue streams and partnerships.
Claritev Corp, formerly known as MultiPlan, operates in the healthcare technology sector, focusing on data and insights to improve transparency, affordability, and quality in healthcare services. With a market capitalization of approximately $400.11 million, the company provides tech-enabled solutions that cater to the needs of the U.S. healthcare industry. Its services include payment integrity, network-based, and analytics-based solutions, aimed at enhancing cost management and revenue integrity.
How Is CTEV Valued?
Currently, GF Value™ data is not available for Claritev Corp. However, the company’s financial metrics provide some context for its valuation. The stock is trading at a price of $23.47, with a price-to-sales (P/S) ratio of 0.4, indicating that investors are paying less than half of the company's revenue per share. This low valuation may suggest that the market is pricing in significant risks, especially in light of the recent investigation. For more details, visit the CTEV stock page.
What Does CTEV's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreâ„¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 58 |
| Financial Strength | 2/10 |
| Profitability | 5/10 |
| Growth | 4/10 |
Claritev Corp's GF Score™ of 58 indicates a moderate potential for long-term returns, but its financial strength is a significant concern, rated at only 2 out of 10. The company’s profitability rank is average, while its growth rank is slightly better at 4 out of 10. These metrics suggest that while there may be some growth potential, the underlying financial health of the company is weak, particularly given the ongoing investigation. For more information, visit the CTEV stock page.
What Are Insiders Doing with CTEV Stock?
In the past three months, there have been four insider buying transactions, totaling 61,130 shares purchased. This activity may indicate that insiders have confidence in the company's long-term prospects despite the current challenges. However, there has been one insider sell transaction in the past year, amounting to $73,005,000, which could raise some concerns about insider sentiment.
What This Means for Investors
The recent DOJ investigation into Claritev Corp presents significant risks that could impact the company's future performance and stock price. While the GF Scoreâ„¢ suggests a moderate potential for long-term returns, the poor financial strength and the ongoing legal scrutiny may deter investors. The insider buying activity could be a positive signal, but the overall financial health of the company raises red flags. For the complete analysis, visit the CTEV stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is CTEV's GF Scoreâ„¢?
CTEV's GF Scoreâ„¢ is 58 out of 100, indicating a moderate potential for long-term returns based on various financial metrics.
How is CTEV valued?
CTEV has a price-to-sales (P/S) ratio of 0.4, suggesting that the stock is trading at a low valuation relative to its revenue, which may reflect the market's concerns about its financial health and ongoing investigation.
What is CTEV's P/E ratio compared to historical?
CTEV does not have a P/E ratio available due to negative earnings; however, its financial strength is rated poorly, with an Altman Z-score of -0.44, indicating potential bankruptcy risk.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
